Clinical insights into the role of bepridil in recurrence prevention after ablation of persistent atrial fibrillation
Bepridil may have a limited role in preventing AF/AT recurrence in PerAF patients, particularly those with severe atrial substrates. However, its overall impact appears to be small, warranting further investigation.
Authors
- Shu Hirata (ORCID: https://orcid.org/0000-0003-0226-466X)
- Kenta Murotani (ORCID: https://orcid.org/0000-0003-0623-9365)
- Masanaru Sawada (ORCID: https://orcid.org/0000-0002-9663-7617)
- Koichi Nagashima (ORCID: https://orcid.org/0000-0003-2326-225X)
- Yasuo Okumura (ORCID: https://orcid.org/0000-0002-2960-4241)
- Moyuru Hirata (ORCID: https://orcid.org/0000-0003-2701-486X)
- Yuji Wakamatsu (ORCID: https://orcid.org/0000-0002-1540-8514)
- Naoto Otsuka
- Ryuta Watanabe (ORCID: https://orcid.org/0000-0003-2664-7139)
- Sayaka Kurokawa (ORCID: https://orcid.org/0000-0002-7989-3985)
- Yuji Saito
Institutions
- Nihon University (JP)
- Kurume University (JP)
Publication Details
- Journal
- Journal of Arrhythmia
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1002/joa3.70083
- Citations
- 1
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.39